@carterra-bio.com
Carterra's industry-leading Monoclonal Antibody (mAb) Characterization & Analysis platform through patented microfluidic tech & SPR imaging.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Carterra is a leading brand in the field of Monoclonal Antibody (mAb) Characterization & Analysis. With their innovative platform, which combines microfluidic technology and SPR imaging, they offer high-throughput antibody screening and characterization. Their products include the Carterra LSA XT, which provides enhanced data quality for demanding applications, and the Carterra LSA Sensor Chips & Solutions.
They also offer various software tools such as Kinetics Software, Epitope Analysis Software, and AI/ML & In Silico tools. Carterra's services include contract assay services and applications for high-throughput kinetics, small molecules, epitope binning, and antibody epitope mapping. Carterra's technology has been instrumental in the discovery and development of therapeutic drugs and vaccines, including the world's first COVID-19 therapeutic, developed by Eli Lilly on the Carterra LSA platform in just 90 days.
Their high-throughput biology solutions are also valuable for artificial intelligence and machine learning strategies. Moreover, Carterra's technology has received positive feedback from industry leaders, with experts highlighting its ability to provide detailed antibody kinetics and epitope binning directly from crude material. Overall, Carterra offers a comprehensive range of products and services that accelerate drug discovery and improve research outcomes
Company Type
Privately Held
Company Size
51-200
Year Founded
2005
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories